Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 32, 2002 - Issue 8
362
Views
63
CrossRef citations to date
0
Altmetric
Research Article

Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers

, , , &
Pages 683-697 | Published online: 22 Sep 2008

References

  • ADAMS, S. S., CLIFFE, E. E., LESSEL, B. and NICHOLSON, J. S., 1967, Some biological properties of 2-(4-isobutylphenyl)propionic acid. Journal of Pharmaceutical Sciences, 56, 1686.
  • AVGERINOS, A. and HUTT, A. J., 1990, Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers. Chira/ity, 2, 249–256.
  • BAILLIE, T. A., ADAMS, W. J., KAISER, D. G., OLANoFF, L. S., HALSTEAD, G. W., HARPOOTLIAN, H. and VAN GIESSEN, G. J., 1989, Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans. Journal of Pharmacology and Experimental Therapeutics, 249, 517–523.
  • BJDRNSDOTTIR, I., KEPP, D. R. TJORNELUND, J. and HANSEN, S. H., 1998, Separation of the enantiomers of ibuprofen and its major phase I metabolites in urine using capillary-electrophoresis. Electrophoresis, 19, 455–460.
  • BROOKS, C. J. W. and GILBERT, M. T., 1974, Studies of urinary metabolites of 2-(4-isobutylphenyl)propionic acid by gas-liquid chromatography-mass spectrometry. Journal of Chromatography, 99, 541–551.
  • CALDWELL, J., HUTT, A. J. and FOURNEL-GIGLEUX, S., 1988, The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochemical Pharmacology, 37, 105–114.
  • CHEN, C.-Y. and CHEN, C.-S., 1994, Stereoselective disposition of ibuprofen in patients with renal dysfunction. Journal of Pharmacology and Experimental Therapeutics, 268, 590–594.
  • DAVIES, N. M., 1998, Clinical pharmacokinetics of ibuprofen. The first 30 years. Clinical Pharmacokinetics, 34, 101–154.
  • EL-MouEuii, M., RUELIUS, H. W., FENSELAU, C. and DULIK, D. M., 1987, Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen and benoxaprofen. Drug Metabolism and Disposition, 15, 767–772.
  • EVANS, A. M., NATION, R. L. and SANSOM, L. N., 1989a, Lack of effect of cirnetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofen. British Journal of Clinical Pharmacology, 28, 143–149.
  • EVANS, A. M., NATION, R. L., SANSOM, L. N. BOCHNER, F. and SOMOGYI, A. A., 1989b, Stereoselective plasma protein binding of ibuprofen enantiomers. European Journal of Clinical Pharmacology, 36, 283–290.
  • EVANS, A. M., NATION, R. L., SANSOM, L. N. BOCHNER, F. and SOMOGYI, A. A., 1990, The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans. Biopharmaceutics and Drug Disposition, 11, 507–518.
  • FANALI, S., DESIDERIO, C., SCHULTE, G., HEITMEIER, S., STRICKMANN, D., CHANKVETADZE, B. and BLASCHKE, G., 1998, Chiral capillary electrophoresis-electrospray mass spectrometry coupling using vancomycin as chiral selector. Journal of Chromatography A, 800, 69–76.
  • FRENEAUX, E., FROMENTY, B., BERSON, A., LABBE, G., DEGOTT, C., LETTERON, P., LARREY, D. and PESSAYNE, D., 1990, Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial O.oxidation of fatty acids. Journal of Pharmacology and Experimental Therapeutics, 255, 529–535.
  • GEISSLINGER, G., SCHUSTER, O., STOCK, K. P., LOEW, D., BACH, G. L. and BRUNE, K., 1990, Pharmacokinetics of S(+ )- and R(-)-ibuprofen in volunteers and first clinical experience of S(+ )-ibuprofen in rheumatoid arthritis. European Journal of Clinical Pharmacology, 38, 493–497.
  • GEISSLINGER, G., STOCK, K. P., LOEW, D., BAcu, G. L. and BRUNE, K., 1993, Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis. British Journal of Clinical Pharmacology, 35, 603–607.
  • HALL, S. D., RUDY, A. C. KNIGHT, P. M. and BRATER, D. C., 1993, Lack of presystemic inversion of (R)- to (S)-ibuprofen in humans. Clinical Pharmacology and Therapeutics, 53, 393–400.
  • HAYBALL, P. J., 1996, Chirality and nonsteroidal anti-inflammatory drugs. Drugs, 52 (Suppl 5), 47–58.
  • HEINZEL, G., WOLOSZCZAK, P. and THOMANN, P. (eds), 1993, Non-compartment analysis-methods manual. In TOPFIT 2.0-Pharmacodynamk Data Analysis System (Stuttgart: Fischer), pp 5–64.
  • HUANG, J. D., 1983, Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis. Journal of Pharmaceutical Sciences, 72, 1368–1369.
  • HUTT, A. J. and CALDWELL, J., 1983, The metabolic chiral inversion of 2-arylpropionic acids — a novel route with pharmacological consequences. Journal of Pharmacy and Pharmacology, 35, 693–704.
  • KAISER, D. G., VAN GIESSEN, G. J., REISCHER, R. J. and WECHTER, W. J., 1976, Isomeric inversion of ibuprofen (R)-enantiomer in humans. Journal of Pharmaceutical Sciences, 65, 269–273.
  • KEPP, D. R., SIDELMANN, U. G. and HANSEN, S. H., 1997, Isolation and characterization of major phase I and II metabolites of ibuprofen. Pharmaceutical Research, 14, 676–680.
  • KNIGHTS, K. M., MCLEAN, C. F., TONKIN, A. L. and MINERS, J. O., 1995, Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans. British Journal of Clinical Pharmacology, 40, 153–156.
  • KNIGHTS, K. M., TALBOT, U. M. and BAILLIE, T. A., 1992, Evidence of multiple forms of rat liver microsomal coenzyme A ligase catalysing the formation of 2-arylpropionyl-coenzyme A thioesters. Biochemical Pharmacology, 44, 2415–2417.
  • KNIHINICKI, R. D., DAY, R. O. and WILLIAMS, K. M., 1989, Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs I. In vitro studies of ibuprofen and flurbiprofen. Biochemical Pharmacology, 38, 4389–4395.
  • KNIHINICKI, R. D., DAY, R. O. and WILLIAMS, K. M., 1991, Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs II. Racemization and hydrolysis of (R)- and (S)-ibupr ofen-Co A thioesters. Biochemical Pharmacology, 42, 1905–1911.
  • LEE, E. J. D., WILLIAMS, K., DAY, R., GRAHAM, G. and CHAMPION, D., 1985, Stereoselective disposition of ibuprofen enantiomers in man. British Journal of Clinical Pharmacology, 19, 669–674.
  • Li, G., TREIBER, G., MAIER, K., WALKER, S. and KLOTZ, U., 1993, Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerations. Clinical Pharmacokinetics, 25, 154–163.
  • LOCKWOOD, G. F., ALBERT, K. S., GILLESPIE, W. R., BOLE, G. G., HARKCOM, T. M., SZPUNAR, G. J. and WAGNER, J. G., 1983, Pharmacokinetics of ibuprofen in man I. Free and total area/dose relationships. Clinical Pharmacology and Therapeutics, 34, 97–103.
  • MAYER, J. M., 1990, Stereoselective metabolism of anti-inflammatory 2-arylpropionates. Ada Pharmaceutica Nordica, 2, 197–215.
  • MENZEL, S., WAIBEL, R., BRUNE, K. and GEISSLINGER, G., 1994, Is the formation of R-ibuprofenyl-adenylate the first stereoselective step of chiral inversion? Biochemical Pharmacology, 48, 1056–1058.
  • MILLS, R. F. N., ADAMS, S. S., CLIFFE, E. E., DICKINSON, W. and NICHOLSON, J. S., 1973, The metabolism of ibuprofen. Xenobiotica, 3, 589–598.
  • PALiwAL, J. K., SMITH, D. E., Cox, S. R., BERARDI, R. R., DUNN-KUCHARSKI, V. A. and ELTA, G. H., 1993, Stereoselective, competitive and nonlinear plasma protein binding of ibuprofen enantiomers as determined in vivo in healthy subjects. Journal of Pharmacokinetics and Biopharmaceutics, 21, 145–161.
  • PETTERSON, J. E., ULSAKER, G. A. and JELLUM, E., 1978, Studies on the metabolism of 2,4'-isobutylphenylpropionic acid (ibuprofen) by gas-chromatography and mass spectrometry. Dialysis fluid, a convenient medium for studies on drug metabolism. Journal of Chromatography. Biomedical Applications, 145, 413–420.
  • ROWLAND, M. and TOZER, T. N., 1995, Metabolite kinetics. In M. Rowland and T. N. Tozer (eds), Clinical Pharmacokinetics, (Philadelphia: Lea & Febiger) pp. 367–394.
  • ROY-DE Vos, M., MAYER, J. M., ETTER, J.C. and TESTA, B., 1996, Clofibric acid increases the unidirectional chiral inversion of ibuprofen in rat liver preparations. Xenobiotica, 26, 571–582.
  • RUDY, A. C., ANLIKER, K. S. and HALL, S. D., 1990, High-performance liquid chromatographic determination of the stereoisomeric metabolites of ibuprofen. Journal of Chromatography. Biomedical Applications, 528, 395–405.
  • RUDY, A. C., BRADLEY, J. D., RYAN, S. I., KALASINSKI, L. A., XIAOTAO, Q. and HALL, S. D., 1992, Variability in the disposition of ibuprofen enantiomers in osteoarthritis patients. Therapeutic Drug Monitoring, 14, 464–470.
  • RUDY, A. C., KNIGHT, P. M., BRATER, D. C. and HALL, S. D., 1991, Stereoselective metabolism of ibuprofen in humans: administration of R- and S- and racemic ibuprofen. Journal of Pharmacology and Experimental Therapeutics, 259, 1133–1139.
  • RUDY, A. C., KNIGHT, P. M., BRATER, D. C. and HALL, S. D., 1995, Enantioselective disposition of ibuprofen in elderly persons with and without renal impairment. Journal of Pharmacology and Experimental Therapeutics, 273, 88–93.
  • SANINS, S. M., ADAMS, W. J., KAISER, D. G., HALSTEAD, G. W., HOSLEY, J., BARNES, H. and BAILLIE, T. A., 1991, Mechanistic studies on the metabolic chiral inversion of R-ibuprofen in the rat. Drug Metabolism and Disposition, 19, 405–410.
  • SCHEUERER, S., HALL, S. D., WILLIAMS, K. M. and GEISSLINGER, G., 1998, Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers. Clinical Pharmacology and Therapeutics, 64, 168–176.
  • SHIEH, W.-R. and CHEN, C.-S., 1993, Purification and characterization of novel `2-arylpropionyl-CoA epimerases' from rat liver cytosol and mitochondria. Journal of Biological Chemistry, 268, 3487–3493.
  • SHIEH, W.-R., Gou, D.-M., Liu, Y.-C., CHEN, C.-S. and CHEN, C.-Y., 1993, A 13C-NNIR study on ibuprofen metabolism in isolated rat liver mitochondria. Analytical Biochemistry, 212, 143–149.
  • SHIRLEY, M. A., GUAN, X., KAISER, D. G., HALSTEAD, G. W. and BAILLIE, T. A., 1994, Taurine conjugation of ibuprofen in humans and in rat liver in vitro. Relationship to metabolic chiral inversion. Journal of Pharmacology and Experimental Therapeutics, 269, 1166–1175.
  • SMITH, D. E., PALiwAL, J. K., Cox, S. R., BERARDI, R. R., DUNN-KUCHARSKI, V. A. and ELTA, G. H., 1994, The effect of competitive and non-linear plasma protein binding on the stereoselective disposition and metabolic inversion of ibuprofen in healthy subjects. Biopharmaceutics and Drug Disposition, 15, 545–561.
  • TAN, S. C., BAKER, J. A., STEVENS, N., DE BIASI, V., SALTER, C., CHALAUX, M., AFARINKIA, K. and HUTT, A. J., 1997a, Synthesis, chromatographic resolution and chiroptical properties of carboxyibuprofen stereoisomers: major metabolites of ibuprofen in man. Chira/ity, 9, 75–87.
  • TAN, S. C., JACKSON, S. H. D., SWIFT, C. G. and HUTT A. J., 1997b, Stereospecific analysis of the major metabolites of ibuprofen in urine by sequential achiral-chiral high-performance liquid chromatography. Journal of Chromatography B, 701, 53–63.
  • TAN, S. C., JACKSON, S. H. D., SWIFT, C. G. and HUTT A. J., 1997c, Enantiospecific analysis of ibuprofen by high-performance liquid chromatography: determination of free and total drug enantiomer concentrations in serum and urine. Chromatographia, 46, 23–32.
  • TRACY, T. S., WIRTHWEIN, D. P. and HALL, S. D., 1993, Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl- coenzymeA. Drug Metabolism and Disposition, 21, 114–120.
  • WECHTER, W. J., LOUGHHEAD, D. G., REISCHER, R. J., VAN GIESSEN, G. J. and KAISER, D. G., 1974, Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R(-)-p-iso-butylhydratropic acid. Biochemical and Biophysical Research Communications, 61, 833–837.
  • WILLIAMS, K. M., DAY, R. O., KNIHINICKI, R. D. and DurriELD, A., 1986, The stereoselective uptake of ibuprofen enantiomers into adipose tissue. Biochemical Pharmacology, 35, 3403–3405.
  • ZNAO, B., GEISSLINGER, G., HALL, I., DAY, R. O. and WILLIAMS, K. M., 1992, The effect of the enantiomers of ibuprofen and flurbiprofen on the O.oxidation of palmitate in the rat. Chirafity, 4, 137–141.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.